Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Risk Management
This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

Objectives

1. Describe the optimum diagnostic techniques and treatment options for patients with urologic malignancies
2. Describe the role of surgery and radiation therapy in the management of urologic malignancies
3. Describe the role of chemotherapy and hormonal therapy in the management of urology malignancies.

Target Audience

The primary target for GU Tumor Board is attending and resident physicians (Urology, Medical Oncology, Radiation Oncology, Pathology, Radiology, Geriatrics) and also nurses and medical students.

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement:

David Wang, Speaker and CME Course Director, has nothing to disclose with regard to commercial interests.

Sakina Flint, RSS Coordinator, has nothing to disclose with regard to commercial interests.

Faculty disclosure of off-label use:

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.